The continued marketing and use of experimental stem cell-based interventions inside and outside the United States is problematic and unsustainable, according to a new paper by science policy and bioethics experts.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1Y1MSHE
No comments:
Post a Comment